2020 annual financial data
ImmuCell Corporation 2020 Operating margin
ImmuCell Corporation 2020 operating margin with verified reported values.
Direct answer
Operating margin was -8.99%.
Operating income was -1,380,000 USD and net income was -1,022,000 USD.
Operating cash flow was 1,315,578 USD.
Get free ImmuCell Corporation email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 15,342,000 USD
- Operating income
- -1,380,000 USD
- Net income
- -1,022,000 USD
- Operating cash flow
- 1,315,578 USD